Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Singapore mandates licensing of moderate to high-risk devices
26 August 2010
Vibha Sharma

All moderate to high-risk medical devices in Singapore have had to comply with licensing requirements as of 10 August for their import, manufacture and wholesale to continue1.

The mandatory requirements for Class C and D devices were introduced by the Health Sciences Authority under Singapore's new medical device regulatory framework, which began being rolled out in November 2007 and is now in the third and final phase of its implementation2...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36